De la Garza-Ramos Cynthia, Salei Aliaksei, Caridi Theresa M
Division of Interventional Radiology, Mayo Clinic, Jacksonville, Florida.
Division of Interventional Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
Semin Intervent Radiol. 2022 Nov 17;39(4):416-420. doi: 10.1055/s-0042-1758077. eCollection 2022 Aug.
The scope of conditions managed by embolization, which was initially used for the treatment of hemorrhage and vascular malformations, is constantly expanding. Apart from oncologic indications, embolization is used to treat a wide range of benign pathology, including uterine fibroids and benign prostatic hyperplasia. While various particulate embolic agents are successfully used for benign embolization, there is growing evidence that unique properties of these may result in different outcomes. This article reviews available evidence comparing various particles used for uterine fibroid embolization and prostate artery embolization. In addition, we provide an overview of periprocedural pharmacology and protocols facilitating same-day discharge for these interventions.
最初用于治疗出血和血管畸形的栓塞术所管理的病症范围正在不断扩大。除了肿瘤学适应症外，栓塞术还用于治疗多种良性病变，包括子宫肌瘤和良性前列腺增生。虽然各种颗粒栓塞剂已成功用于良性栓塞，但越来越多的证据表明，这些栓塞剂的独特特性可能会导致不同的结果。本文综述了比较用于子宫肌瘤栓塞和前列腺动脉栓塞的各种颗粒的现有证据。此外，我们还概述了围手术期药理学以及有助于这些干预措施实现当日出院的方案。
